Exacerbation reduction data with benralizumab in subgroups of patients with severe eosinophilic asthma (SEA) from Central Europe and Baltics (BREEZE)
Year: 2024
Type: conference-paper
Study design: Observational Study
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404127303
